Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $134,336 | 65 | 52.8% |
| Travel and Lodging | $46,995 | 66 | 18.5% |
| Food and Beverage | $34,536 | 834 | 13.6% |
| Consulting Fee | $20,413 | 14 | 8.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $16,500 | 5 | 6.5% |
| Honoraria | $1,500 | 1 | 0.6% |
| Education | $98.79 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $60,336 | 58 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45,745 | 65 | $0 (2022) |
| Penumbra, Inc. | $34,022 | 40 | $0 (2024) |
| Lilly USA, LLC | $25,024 | 38 | $0 (2021) |
| ShockWave Medical, Inc | $19,168 | 45 | $0 (2023) |
| Aralez Pharmaceuticals US Inc. | $12,450 | 22 | $0 (2017) |
| Medtronic, Inc. | $10,845 | 51 | $0 (2024) |
| Terumo Medical Corporation | $7,687 | 17 | $0 (2024) |
| Amarin Pharma Inc. | $6,541 | 18 | $0 (2022) |
| Boston Scientific Corporation | $5,941 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,801 | 74 | Penumbra, Inc. ($10,709) |
| 2023 | $28,039 | 121 | Penumbra, Inc. ($12,255) |
| 2022 | $33,781 | 142 | Medtronic, Inc. ($8,476) |
| 2021 | $13,184 | 97 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,121) |
| 2020 | $16,742 | 65 | Amarin Pharma Inc. ($6,319) |
| 2019 | $52,423 | 165 | Boehringer Ingelheim Pharmaceuticals, Inc. ($26,043) |
| 2018 | $35,519 | 156 | Gilead Sciences, Inc. ($16,304) |
| 2017 | $61,890 | 168 | Gilead Sciences Inc ($44,032) |
All Payment Transactions
988 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $123.17 | General |
| Category: Renal Denervation System | ||||||
| 12/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Heart Failure | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Heart Failure | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.79 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Genetic Disease | ||||||
| 10/29/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $27.89 | General |
| Category: Endovascular | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Heart Failure | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: Heart Failure | ||||||
| 10/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $161.16 | General |
| 09/20/2024 | Penumbra, Inc. | Indigo System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Peripheral Intervention | ||||||
| 09/20/2024 | Penumbra, Inc. | Indigo System (Device) | Travel and Lodging | Cash or cash equivalent | $353.71 | General |
| Category: Peripheral Intervention | ||||||
| 09/18/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.44 | General |
| Category: Endovascular | ||||||
| 09/12/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $24.08 | General |
| Category: Coronary | ||||||
| 09/10/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Heart Failure | ||||||
| 08/29/2024 | Penumbra, Inc. | Indigo System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Peripheral Intervention | ||||||
| 08/22/2024 | Abbott Laboratories | ESPRIT (Device) | Food and Beverage | In-kind items and services | $40.38 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 52 | 5,232 | 11,194 | $5.8M | $928,420 |
| 2022 | 52 | 4,914 | 12,251 | $5.5M | $775,651 |
| 2021 | 54 | 6,435 | 14,781 | $4.1M | $934,094 |
| 2020 | 41 | 4,248 | 5,773 | $2.1M | $473,472 |
All Medicare Procedures & Services
217 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 149 | 152 | $1.1M | $256,959 | 23.9% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 180 | 192 | $594,504 | $123,557 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 688 | 1,004 | $409,080 | $88,532 | 21.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 104 | 106 | $278,672 | $62,687 | 22.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 257 | 1,625 | $391,150 | $54,847 | 14.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 222 | 1,578 | $439,826 | $52,528 | 11.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 346 | 350 | $400,662 | $44,379 | 11.1% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 32 | 32 | $391,490 | $33,102 | 8.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 184 | 752 | $191,760 | $31,966 | 16.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 32 | 48 | $147,290 | $18,760 | 12.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 233 | 644 | $133,722 | $17,601 | 13.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 98 | 103 | $65,744 | $13,303 | 20.2% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 132 | 233 | $45,104 | $10,791 | 23.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 188 | 193 | $73,984 | $9,874 | 13.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 55 | 56 | $94,110 | $9,366 | 10.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 176 | 185 | $58,949 | $8,964 | 15.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 91 | $29,986 | $8,008 | 26.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 49 | 335 | $64,256 | $7,846 | 12.2% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 254 | 255 | $313,240 | $6,239 | 2.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 569 | 900 | $24,300 | $5,421 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $25,819 | $5,186 | 20.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 40 | 285 | $37,971 | $4,932 | 13.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 104 | 333 | $43,776 | $4,680 | 10.7% |
| 0715T | Shockwave destruction of calcified plaque in coronary artery accessed through skin using catheter | Facility | 2023 | 29 | 35 | $32,550 | $4,390 | 13.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 59 | 76 | $19,435 | $4,102 | 21.1% |
About Dr. Corey Foster, MD
Dr. Corey Foster, MD is a Cardiovascular Disease healthcare provider based in Lake Charles, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669693867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Corey Foster, MD has received a total of $254,379 in payments from pharmaceutical and medical device companies, with $12,801 received in 2024. These payments were reported across 988 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($134,336).
As a Medicare-enrolled provider, Foster has provided services to 20,829 Medicare beneficiaries, totaling 43,999 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 217 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties General Practice
- Location Lake Charles, LA
- Active Since 05/02/2007
- Last Updated 06/10/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1669693867
Products in Payments
- JARDIANCE (Drug) $70,191
- Ranexa (Drug) $60,142
- Indigo System (Device) $33,790
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $18,770
- YOSPRALA (Drug) $12,414
- COREVALVE EVOLUT R (Device) $9,635
- Vascepa (Drug) $6,541
- GLIDEWIRE (Device) $5,200
- WATCHMAN (Device) $4,515
- Impella (Device) $4,474
- LifeVest (Device) $3,878
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $3,819
- CoreValve Evolut (Device) $1,649
- Diamondback Peripheral (Device) $1,266
- ELIQUIS (Drug) $989.57
- CardioMEMS HF System (Device) $786.99
- ENTRESTO (Drug) $705.01
- GLIDESHEATH SLENDER (Device) $507.82
- XARELTO (Drug) $477.07
- NAVICROSS (Device) $400.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lake Charles
Richard Gilmore, Md, MD
Cardiovascular Disease — Payments: $62,090
Dr. John Winterton, M.d, M.D
Cardiovascular Disease — Payments: $56,433
Dr. Kevin Young, Md, MD
Cardiovascular Disease — Payments: $36,488
Dr. Jake Lebeau, Md, MD
Cardiovascular Disease — Payments: $17,953
Dr. Carriel Nipp, M.d, M.D
Cardiovascular Disease — Payments: $13,623
Dr. Jean White, Md, MD
Cardiovascular Disease — Payments: $6,399